Institute of Life Science Phase Two Professor Gareth Morgan Head of School

School of Medicine Established in 2001, the School of Medicine at Swansea University aims to be a centre of excellence in world-class research and medical education Principal activities are: Education: Four-year Graduate Entry Medicine Programme, BSc Genetics and Medical Genetics Programmes and Higher degree programmes including PhD, MD, MCh and Masters degrees Research: Interdisciplinary biomedical and health services research at the Institute of Life Science where 87% of research staff have been recognised as producing research of international quality or above (RAE2008) Third Mission: The School of Medicine is also fulfilling its third mission obligations at the Institute of Life Science

Institute of Life Science Phase One 5000m2 Four floors of laboratory space Incubator space is fully occupied Cafe Glas has become a hive of activity Highlights IBM supercomputer – Blue C Boots Centre for Innovation Calon Cardio-Technology Seren Bioscience Maimonidex UK Allerna Therapeutics London Women’s Clinic RAE2008 Results Grant income Publication performance Visits from First and Prime Ministers Visits from Health and Economic Ministers ILS Phase One

Institute of Life Science Phase Two 5000m2 CHIRAL – Health Services Research, Clinical Trials Unit, Health Informatics (HIRU + HIRL) Clinical Research Facility Centre for NanoHealth Research Imaging Business Incubation Innovation and Enterprise Mass Spectrometry Facts£28.8m bringing total value of ILS to £80million (over £100m with CNH) £16m Capital build £10m Grant from Department of Health Tripling of business incubation space Moving more than 100 people from Grove Ground-breaking November 2009 Completion early summer 2011 Proposed view of ILS Phase Two from Swansea University

Abertawe Bro Morgannwg University NHS Trust ABM University Trust is a key partner in ILS Phase 2. It is involved in the following ways: Donation of land worth £1 million to the project Integration with current Trust Clinical Research Unit Medical imaging Health informatics Ambulatory Care Centre Proposed view of ILS Phase Two from Singleton Hospital

Our Obligations In order for ILS Phase Two to be a success, we need to deliver a range of project outcomes: Create 450 high value jobs in three years Assist commercial enterprises, 80% of which must be Welsh SMEs Populate fifteen units within the incubator space Record daily activity on the project including timesheets and enterprise assistance Continue to undertake high quality research that advances medical knowledge

Institute of Life Science Thank you very much to everyone who has been involved in securing ILS Phase Two: All ILS researchers and client organisations All School of Medicine staff Operational Management Group ILS Executive Innovation and Enterprise team Central University staff Wales European Funding Office Welsh Assembly Government Departments for Economic Development and Health